TGTX
#995
TG Therapeutics, Inc. - Common Stock
58.2 2 USD
+0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+2.32%
Changement Mensuel
+26.13%
Evolution sur 6 mois
+100.55%
Changement Annuel
+84.47%
Clôture Précédente
56.9 0
Open
57.2 8
Low
57.2 3
High
58.2 7
Volume
409
Financials
- Market Capitalization 8.91 B
- Employee 399
- Founded 1993
- CEO Michael S Weiss
- Website www.tgtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000FVZQY1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
20.05
ratio cours/chiffre d'affaires
10.98
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 977 |  PCVX Vaxcyte, Inc. - Common Stock | 61.51 USD | -0.11% | -0.02% | +12.95% | +45.41% | 9.15 B USD | ||
| 987 |  ABVX Abivax SA - American Depositary Shares | 114.81 USD | +3.36% | -0.91% | -8.16% | +37.93% | 9.02 B USD | ||
| 1014 |  IBRX ImmunityBio, Inc. - Common Stock | 7.96 USD | +0.13% | -7.66% | +17.23% | +234.45% | 8.44 B USD | ||
| 1015 |  APGE Apogee Therapeutics, Inc. - Common Stock | 135.07 USD | -0.01% | +0.07% | +0.61% | +152.04% | 8.40 B USD |